Transcriptional profiling of CD133⁺ cells in coronary artery disease and effects of exercise on gene expression

By Liu Delong   Glaser Alexander P.   Patibandla Sushmitha   Blum Arnon   Munson Peter J.   McCoy J. Philip   Raghavachari Nalini   Cannon Richard O.  

Cytotherapy, Vol. 13, Iss. 2, 2011-02 ,pp. : 227-236

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34- AML patients express CD33

By Vercauteren Sm   Zapf R.   Sutherland Hj  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 194-204

Ashgate Publishing Ltd

Access to resources Recommend Favorite

κ-opioids induce a reversible inhibition of CFU-GM from CD133 + cord blood cells

By Dimitriou H   Bakogeorgou E   Kampa M   Notas G   Stiakaki E   Kouroumalis E   Kalmanti M   Castanas E  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 367-374

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Autologous transplantation of CD133 + BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy

By Ghodsizad A   Ruhparwar A   Marktanner R   Borowski A   Mohammad Hasani Mr   Poll L   Vshivkov I   Stoldt V   Voelkel T   Piechaczek C   Burchardt Er   Stockschlaeder M   Sucker C   Gams E   Klein Hm  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 308-310

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up

By Cañizo MC   Lozano F.   González-Porras JR   Barros M.   López-Holgado N.   Briz E.   Sánchez-Guijo FM  

Cytotherapy, Vol. 9, Iss. 1, 2007-01 ,pp. : 99-102

Ashgate Publishing Ltd

Access to resources Recommend Favorite